Syncom Formulations India Ltd (SYFI)

Currency in INR
18.33
+0.10(+0.55%)
Closed·
SYFI Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
SYFI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.1018.50
52 wk Range
14.1027.94
Key Statistics
Bid/Ask
18.21 / 18.33
Prev. Close
18.23
Open
18.17
Day's Range
18.1-18.5
52 wk Range
14.1-27.94
Volume
224.58K
Average Volume (3m)
628.37K
1-Year Change
20.89%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SYFI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Syncom Formulations India Ltd Company Profile

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations. It provides life care, evolve, and right nutrition products under the Cratus brand. In addition, the company engages in the trading of commodities and renting of properties. It also exports its products. The company offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

Employees
998
Market
India

Compare SYFI to Peers and Sector

Metrics to compare
SYFI
Peers
Sector
Relationship
P/E Ratio
34.9x6.1x−0.5x
PEG Ratio
0.310.050.00
Price/Book
5.0x1.1x2.6x
Price / LTM Sales
3.7x0.9x3.2x
Upside (Analyst Target)
-0.0%42.7%
Fair Value Upside
Unlock5.9%5.8%Unlock

Earnings

Latest Release
May 19, 2025
EPS / Forecast
0.16 / --
Revenue / Forecast
1.56B / --
EPS Revisions
Last 90 days

SYFI Income Statement

People Also Watch

2,138.80
GLEN
-0.89%
3,553.70
TORP
+1.43%
5,298.00
LTIM
+2.37%
161.31
GPPL
-0.20%
3,533.70
TIMK
+0.95%

FAQ

What Stock Exchange Does Syncom Formulations India Trade On?

Syncom Formulations India is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Syncom Formulations India?

The stock symbol for Syncom Formulations India is "SYFI."

What Is the Syncom Formulations India Market Cap?

As of today, Syncom Formulations India market cap is 17.28B.

What Is Syncom Formulations India's Earnings Per Share (TTM)?

The Syncom Formulations India EPS (TTM) is 0.57.

From a Technical Analysis Perspective, Is SYFI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Syncom Formulations India Stock Split?

Syncom Formulations India has split 2 times.

How Many Employees Does Syncom Formulations India Have?

Syncom Formulations India has 998 employees.

What is the current trading status of Syncom Formulations India (SYFI)?

As of 23 Jul 2025, Syncom Formulations India (SYFI) is trading at a price of 18.33, with a previous close of 18.23. The stock has fluctuated within a day range of 18.10 to 18.50, while its 52-week range spans from 14.10 to 27.94.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.